Antitumor vaccine effect of irradiated murine neuroblastoma cells producing interleukin-2 or granulocyte macrophage-colony stimulating factor

International Journal of Oncology

Volumn 13, Issue 1, 1998, Pages 73-78

  Yoshida, Hideo ^a   Enomoto, Hideki ^a   Kawamura, Kiyoko ^b   Takenaga, Keizo ^c   Tanabe, Masahiro ^a   Ohnuma, Naomi ^a   Sakiyama, Shigeru ^d   Tagawa, Masatoshi ^b,d  

^a CHIBA UNIVERSITY   (Japan)

^b Division of Pathology   (Japan)

^c Division of Chemotherapy   (Japan)

^d CHIBA CANCER CENTER   (Japan)

Author keywords

Granulocyte macrophage colony stimulation factor; Interleukin 2; Neuroblastoma

Indexed keywords

CANCER ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; TUMOR VACCINE;

ANIMAL CELL; ARTICLE; CANCER CONTROL; CELL GROWTH; GENE EXPRESSION; IN VITRO STUDY; IRRADIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR IMMUNITY; VACCINATION;

EID: 0031860203     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.1.73     Document Type: Article

References (23)

1. Tuting T, Storkus WJ and Lotz MT: Gene-based strategies for the immunotherapy of cancer. J Mol Med 75: 478-491, 1997.
2. Tepper RI and Mulé JJ: Experimental and clinical studies of cytokine gene-modified tumor cells. Hum Gene Ther 5: 153-164, 1994.
3. Golumbek PT, Lazenby AJ, Levitsky HI, Jaffee LM, Karasuyama H, Baker M and Pardoll DM: Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254: 713-716, 1991.
4. Hollingsworth SJ, Darling D, Gäken J, Hirst W, Patel P, Kuiper M, Towner P, Humphreys S, Farzaneh F and Mufti GJ: The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanoma. Br J Cancer 74: 6-15, 1996.
5. Yu JS, Burwick JA, Dranoff G and Breakefield XO: Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells. Hum Gene Ther 8: 1065-1072, 1997.
6. Gunji Y, Tagawa M, Matsubara H, Takenaga K, Shimada H, Kondo F, Suzuki T, Nakajima K, Aoki T, Asano T, Ochiai T, Isono K, Kageyama H, Nakamura Y and Sakiyama S: Murine colon carcinoma cells engineered to produce human interleukin-2 induce tumor-specific anti-tumor response. Int J Cancer 66: 135-139, 1996.
7. Rodolfo M, Zilocchi C, Melani C, Cappetti B, Arioli I, Parmiani G and Colombo MP: Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. J Immunol 157: 5536-5542, 1996.
8. Matsubara H, Tagawa M, Gunji Y, Takenage K, Sugaya M, Urashima T, Koide Y, Suzuki T, Asano T, Ochiai T, Isono K, Kageyama H, Nakamura Y and Sakiyama S: Study of irradiation effects on cytokine secretion from retrovirally-transduced tumor cells: a model for tumor vaccination. Anticancer Res 16: 645-650, 1996.
9. Carlsen NLT: How frequent is spontaneous remission of neuroblastomas? Implications for screening. Br J Cancer 61: 441-446, 1990.
10. Watanabe Y, Kuribayashi K, Miyatake S, Nishihara K, Nakayana E, Taniyama T and Sakata T: Exogenous expression of mouse interferon γ cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented antitumor immunity. Proc Natl Acad Sci USA 86: 9456-9460, 1989.
11. Katsanis E, Orchard PJ, Bausero MA, Gorden KB, McIvor RS and Blazar BR: Interleukin-2 gene transfer into murine neuroblastoma decreases tumorigenicity and enhances systemic immunity causing regression of preestablished retroperitoneal tumors. J Immunother 15: 81-90, 1994.
12. Yoshida H, Enomoto H, Tagawa M, Takenaga K, Tasaki K, Nakagawara A, Ohnuma N, Takahashi H and Sakiyama S: Impaired tumorigenicity and decreased liver metastasis of murine neuroblastoma cells engineered to secrete interleukin-2 or granulocyte macrophage-colony stimulating factor. Cancer Gene Ther 5: 67-73, 1998.
13. Miller AD and Rosman GJ: Improved retroviral vectors for gene transfer and expression. Biotechniques 7: 980-990, 1989.
14. Yamada G, Kitamura Y, Sonoda H, Harada H, Taki S, Mulligan RC, Osawa H, Diamantstein T, Yokoyama S and Taniguchi T: Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity. EMBO J 6: 2705-2709, 1987.
15. Miyatake S, Otsuka T, Yokota T, Lee F and Arai K: Structure of the chromosomal gene for granulocyte-macrophage colony stimulating factor: comparison of the mouse and human genes. EMBO J 4: 2561-2568, 1985.
16. Kimura M, Tagawa M, Takenaga K, Nakagawara A, Horitsu K, Yamaguchi T, Saisho H and Sakiyama S: Drug resistance to ganciclovir observed in suicide gene therapy is due to the loss of integrated herpes simplex virus-thymidine kinase gene. Int J Oncol 10: 775-778, 1997.
17. Yoshida H, Enomoto H, Miyauchi M, Takenaga K, Tanabe M, Ohnuma N, Sakiyama S and Tagawa M: Impaired tumorigenicity of IL-4-producing murine neuroblastoma cells in immunodeficient nude mice. Int J Oncol 12: 1067-1071, 1998.
18. Arienti F. Sulé-Suso J. Meiani C. Maecalli C. Belli F. Illent ME. Anichini A. Caseinelli N. Colombo NIP and Parmiani G: Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-umestricted and MHC-restricted autologous lymphocytes. Hum Gene Ther 5: 1139-1150. 1994.
19. Belldegrun A, Tso C-L. Sakata T, Duckett T, Brunda MJ, Barsky SH, Chai J, Kaboo R, Lavey RS, McBride WH and de Kernion JB: Human renal carcinoma line transfected with interleukin-2 and/or interferon a gene(s): implications for live cancer vaccines. J Natl Cancer Inst 85: 207-216. 1993.
20. Gastl G. Finstad CL. Guarini A. Bosl G. Gilboa E. Bander NH and Gansbacher B: Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells. Cancer Res 52, 6229-6236. 1992.
21. Gansbacher B. Zier K. Cronin K. Hamzopoulos PA, Bouchard B. Houghton A. Gilboa E and Golde D: Retroviral gene transfer induced constintive expression of interleukin-2 or interferon-γ in irradiated human melanoma cells. Blood 80: 2817-2825. 1992.
22. Sehmidt W. Sehweighoffer T. Herbst E. Maass G. Berger M. Schileher F. Schaffner G and Birnstiel ML. Cancer vaceines. the interleukin 2 dosage effect. Proc Natl Acad Sci USA 92: 4711-4714. 1995.
23. Abe J, Wakimoto H, Yoshida Y, Aoyagi M, Hirakawa K and Hamada H: Antitumor effect induced by granulocyte/macrophage-colony-stimulating factor gene-modified tumor evaccination: c ompanson of adenovirus- and retrovirus-mediated genetic transduction. J Cancer Res Clin Oncol 121: 587-592, 1995.